Growth Metrics

TherapeuticsMD (TXMD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $4.9 million.

  • TherapeuticsMD's Total Current Liabilities fell 1725.23% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 1725.23%. This contributed to the annual value of $5.2 million for FY2024, which is 2462.8% down from last year.
  • As of Q3 2025, TherapeuticsMD's Total Current Liabilities stood at $4.9 million, which was down 1725.23% from $4.7 million recorded in Q2 2025.
  • TherapeuticsMD's 5-year Total Current Liabilities high stood at $264.8 million for Q1 2022, and its period low was $4.7 million during Q2 2025.
  • For the 5-year period, TherapeuticsMD's Total Current Liabilities averaged around $64.1 million, with its median value being $14.5 million (2023).
  • Per our database at Business Quant, TherapeuticsMD's Total Current Liabilities soared by 33214.38% in 2022 and then tumbled by 9269.89% in 2023.
  • Over the past 5 years, TherapeuticsMD's Total Current Liabilities (Quarter) stood at $252.9 million in 2021, then plummeted by 81.48% to $46.8 million in 2022, then plummeted by 85.37% to $6.9 million in 2023, then fell by 24.63% to $5.2 million in 2024, then dropped by 4.28% to $4.9 million in 2025.
  • Its Total Current Liabilities stands at $4.9 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.7 million for Q1 2025.